[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Perween et al., 2021 - Google Patents

Investigating the feasibility of mefenamic acid nanosuspension for pediatric delivery: Preparation, characterization, and role of excipients

Perween et al., 2021

View HTML
Document ID
579695059589218954
Author
Perween N
Alshehri S
Easwari T
Verma V
Faiyazuddin M
Alanazi A
Shakeel F
Publication year
Publication venue
Processes

External Links

Snippet

Molecules with poor aqueous solubility are difficult to formulate using conventional approaches and are associated with many formulation delivery issues. To overcome these obstacles, nanosuspension technology can be one of the promising approaches. Hence, in …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Choi et al. Effects of polymers on the drug solubility and dissolution enhancement of poorly water-soluble rivaroxaban
Czajkowska-Kośnik et al. Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin
Giri et al. Improved bioavailability and high photostability of methotrexate by spray-dried surface-attached solid dispersion with an aqueous medium
Ding et al. Enhanced oral bioavailability of celecoxib nanocrystalline solid dispersion based on wet media milling technique: formulation, optimization and in vitro/in vivo evaluation
Vaculikova et al. Preparation of candesartan and atorvastatin nanoparticles by solvent evaporation
Mehenni et al. Preparation and characterization of spherical amorphous solid dispersion with amphotericin B
Sammour et al. Optimization of aceclofenac proniosomes by using different carriers, part 1: Development and characterization
Vehlow et al. Polyelectrolyte complex based interfacial drug delivery system with controlled loading and improved release performance for bone therapeutics
Rachmawati et al. Destabilization mechanism of ionic surfactant on curcumin nanocrystal against electrolytes
Nasr et al. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles
Kang et al. Exploring the preparation of albendazole-loaded chitosan-tripolyphosphate nanoparticles
Li et al. Hydroxypropyl-β-cyclodextrin for delivery of baicalin via inclusion complexation by supercritical fluid encapsulation
Perween et al. Investigating the feasibility of mefenamic acid nanosuspension for pediatric delivery: Preparation, characterization, and role of excipients
Marslin et al. Solid lipid nanoparticles of albendazole for enhancing cellular uptake and cytotoxicity against U-87 MG glioma cell lines
Nagai et al. Oral administration system based on meloxicam nanocrystals: Decreased dose due to high bioavailability attenuates risk of gastrointestinal side effects
Sun et al. Nanoformulation of a novel pyrano [2, 3-c] pyrazole heterocyclic compound AMDPC exhibits anti-cancer activity via blocking the cell cycle through a P53-independent pathway
Alshehri et al. Formulation, in vitro and in vivo evaluation of gefitinib solid dispersions prepared using different techniques
Zhao et al. Effect of carrier lipophilicity and preparation method on the properties of andrographolide–solid dispersion
Vaculikova et al. Preparation of hydrochlorothiazide nanoparticles for solubility enhancement
Cho et al. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® E
Kim et al. Comparison of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded self-emulsifying granule and solid self-nanoemulsifying drug delivery system: powder property, dissolution and oral bioavailability
Hassan et al. Rutin nanocrystals with enhanced anti-inflammatory activity: Preparation and ex vivo/in vivo evaluation in an inflammatory rat model
Vaculikova et al. Preparation of risedronate nanoparticles by solvent evaporation technique
Phan et al. Impact of crystal habit on the dissolution rate and in vivo pharmacokinetics of sorafenib tosylate
Varan et al. Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3d breast tumor model